- Global Pharma News & Resources

Drägerwerk AG & Co. KGaA: Dräger agrees with the federal government to end the delivery of ventilators

Drägerwerk AG & Co. KGaA / Key word(s): Agreement
Drägerwerk AG & Co. KGaA: Dräger agrees with the federal government to end the delivery of ventilators

10-Sep-2020 / 16:28 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Ad-hoc notification in accordance with Sec. 17 of the MAR

Drägerwerk AG & Co. KGaA: Dräger agrees with the federal government to end the delivery of ventilators

In March, Dräger received a major order from the federal government for the delivery of 10,000 ventilators. Thereby, the federal government ensured sufficient supply for the health care system in Germany in times of great uncertainty due to COVID-19. Since the beginning of the pandemic, Dräger has been in close contact with the federal government and many other customers around the world. Considering the current status of the development of the pandemic in Germany and other countries, Dräger and the federal government have now agreed in principle that Dräger will not deliver any more devices to the federal government beyond the 1,557 already delivered. The federal government bears the costs incurred for providing and upholding the production capacity. The capacities that are now being freed up enable Dräger to supply other important markets outside Germany with ventilators that are still urgently needed there.
Dräger's guidance published on July 14th remains unchanged. Accordingly, Dräger expects currency-adjusted net sales growth of 14 to 22 percent for 2020. The EBIT margin is expected to be between 7.0 and 11.0 percent.

Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23558 Lübeck, Deutschland

Investor Relations:
Thomas Fischler
Tel. +49 451 882-2685

Corporate Communications:
Melanie Kamann
Tel. +49 451 882-3998

This ad hoc report contains statements on the future development of Dräger Group. These forward-looking statements are based on the current expectations, presumptions, and forecasts of the Executive Board as well as the information available to date. They were compiled to the best of the company's knowledge. Dräger does not provide any warranty nor assume any responsibility for the future developments and results described above. These are dependent on a number of factors. They entail various risks and contingencies outside of the company's influence and are based on assumptions which could prove to be incorrect. Dräger does not assume any responsibility for updating the forward-looking statements contained in this report. This does not infringe any legal stipulations on the adjustment of forecasts. Please go to Investor Relations / Definitions of financial indicators at for information on alternative performance measures used.

10-Sep-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at

Language: English
Company: Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23542 Lübeck
Phone: +49 (0)451 882-0
Fax: +49 (0)451 882-2080
ISIN: DE0005550602, DE 000 555 063 6, DE 000 555 065 1, DE 000 555 067 7, DE 000 555 071 9
WKN: 555060, 555063 Vorzüge, 555065 Genussschein A, 555067 Genussschein K, 555071 Genussschein D
Indices: TecDAX
Listed: Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime Standard), Hamburg, Hanover, Munich; Regulated Unofficial Market in Stuttgart, Tradegate Exchange
EQS News ID: 1130085

End of Announcement DGAP News Service

Editor Details

Last Updated: 10-Sep-2020